advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (23)
Showing records 1 to 23
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation27494 Efficacy and patient tolerability of travoprost bak-free solution in patients with open-angle glaucoma and ocular hypertension
Mirza SK; Johnson SM
Clinical Ophthalmology 2010; 4: 877-888
27488 Tolerability and effectiveness of preservativefree dorzolamide-timolol (preservative-free COSOPT((registered trademark))) in patients with open-angle glaucoma or ocular hypertension
Hutnik C; Neima D; Ibrahim F; Scott R; Vaillancourt J; Haine D; Sampalis JS; Bastien N; Foucart S
Clinical Ophthalmology 2010; 4: 581-590
27287 Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT(trademark)) in patients with elevated intraocular pressure in a randomized clinical trial
Shedden A; Adamsons IA; Getson AJ; Laurence JK; Lines CR; Hewitt DJ; Ho TW
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 1757-1764
27319 Reduction in intraocular pressure by the instillation of eye drops containing disulfiram included with 2-hydroxypropyl-(beta)-cyclodextrin in rabbit
Ito Y; Nagai N; Shimomura Y
Biological & Pharmaceutical Bulletin 2010; 33: 1574-1578
27543 Changing the composition of buffered eye-drops prevents undesired side effects
Schrage NF; Frentz M; Reim M
The British journal of ophthalmology 2010; 94: 1519-1522
27647 Ocular drug delivery from molecularly-imprinted contact lenses
Alvarez-Lorenzo C; Yanez F; Concheiro A
Journal of Drug Delivery Science and Technology 2010; 20: 237-248
27123 Nanotechnology in ophthalmology
Zarbin MA; Montemagno C; Leary JF; Ritch R
Canadian Journal of Ophthalmology 2010; 45: 457-476
27136 Optical fiber-coupled ocular spectrometer for measurement of drug concentration in the anterior eye-applications in pharmaceuticals research
Miller J; Wilson WS; Blue R; Wilson CG; Uttamchandani D
IEEE Transactions on Bio-Medical Engineering 2010; 57: 2903-2909
27138 In vitro and in vivo evaluation of stimuli sensitive hydrogel for ophthalmic drug delivery
Singh V; Busheetti SS; Raju SA; Ahmad R; Singh M
Indian Journal of Pharmaceutical Education and Research 2010; 44: 380-385
27355 Ocular pharmacokinetics of methazolamide ophthalmic suspension in rabbit aqueous humor
Liu W; Gan Y; Gan L; Ping Q-N; Cao F; Xiao Y-Y
Journal of China Pharmaceutical University 2010; 41: 337-341
27307 Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells
Ammar DA; Noecker RJ; Kahook MY
Advances in Therapy 2010; 27: 837-845
27323 Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspension
Jansook P; Stefansson E; Thorsteinsdottir M; Sigurdsson BB; Kristjansdottir SS; Bas JF; Sigurdsson HH; Loftsson T
European Journal of Pharmaceutics and Biopharmaceutics 2010; 76: 208-214
27523 Applications of nanoparticles in ophthalmology
Diebold Y; Calonge M
Progress in Retinal and Eye Research 2010; 29: 596-609
27005 Preservatives in eye drops: toward awareness of their toxicity.
Vaede D; Baudouin C; Warnet JM; Brignole-Baudouin F
Journal Français d'Ophtalmologie 2010; 33: 505-524
27209 Medical devices for the treatment of eye diseases
Yasukawa T; Ogura Y
Handb Exp Pharmacol 2010; 197: 469-489
27556 Trends in ophthalmic preservatives: A review
Barot M; Gokulgandhi MR; Parikh JR
Drug Delivery Technology 2010; 10: 46-49
27555 New devices for dispensing ophthalmic treatments may be the key to managing the life cycles of established products
Birkhoff M; Marx D
Drug Delivery Technology 2010; 10: 16-21
27354 Preparation and characterization of timolol maleate ocular films
Rathore KS; Nema RK; Sisodia SS
International Journal of PharmTech Research 2010; 2: 1995-2000
27502 Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines
Ayaki M; Iwasawa A
Clinical Ophthalmology 2010; 4: 919-924
27305 Biodegradable implants for sustained drug release in the eye
Lee SS; Hughes P; Ross AD; Robinson MR
Pharmaceutical Research 2010; 27: 2043-2053
27264 Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide
Qian Y; Wang F; Li R; Zhang Q; Xu Q
Drug Development and Industrial Pharmacy 2010; 36: 1340-1347
27118 Changing the composition of buffered eye-drops prevents undesired side effects
Schrage NF; Frentz M; Reim M
British Journal of Ophthalmology 2010; 94: 1519-1522
27296 Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system
Kaur IP; Aggarwal D; Singh H; Kakkar S
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 1467-1472
